Renin-Angiotensin-Aldosterone Inhibitors and COVID-19

被引：0
|
作者：
Benenson, Irina [1 ]
Waldron, Frederick [2 ]
机构：
[1] Rutgers State Univ, Sch Nursing, Newark, NJ 07102 USA
[2] Newark Beth Israel Med Ctr, Dept Emergency Med, Newark, NJ USA
来源：
JNP-JOURNAL FOR NURSE PRACTITIONERS | 2020年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.nurpra.2020.05.007
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
[No abstract available]
引用
收藏
页码：545 / 546
页数：2
相关论文
共 50 条
  • [41] Is Spironolactone the Preferred Renin-Angiotensin-Aldosterone Inhibitor for Protection Against COVID-19?
    Wilcox, Christopher S.
    Pitt, Bertram
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2021, 77 (03) : 323 - 331
  • [42] COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system
    Susanne Rysz
    Jonathan Al-Saadi
    Anna Sjöström
    Maria Farm
    Francesca Campoccia Jalde
    Michael Plattén
    Helen Eriksson
    Margareta Klein
    Roberto Vargas-Paris
    Sven Nyrén
    Goran Abdula
    Russell Ouellette
    Tobias Granberg
    Malin Jonsson Fagerlund
    Johan Lundberg
    Nature Communications, 12
  • [43] The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19
    Mascolo, Annamaria
    Scavone, Cristina
    Rafaniello, Concetta
    De Angelis, Antonella
    Urbanek, Konrad
    di Mauro, Gabriella
    Cappetta, Donato
    Berrino, Liberato
    Rossi, Francesco
    Capuano, Annalisa
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [44] COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system
    Rysz, Susanne
    Al-Saadi, Jonathan
    Sjostrom, Anna
    Farm, Maria
    Jalde, Francesca Campoccia
    Platten, Michael
    Eriksson, Helen
    Klein, Margareta
    Vargas-Paris, Roberto
    Nyren, Sven
    Abdula, Goran
    Ouellette, Russell
    Granberg, Tobias
    Fagerlund, Malin Jonsson
    Lundberg, Johan
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [45] Clinical Features of COVID-19 in Patients With Essential Hypertension and the Impacts of Renin-angiotensin-aldosterone System Inhibitors on the Prognosis of COVID-19 Patients
    Pan, Wei
    Zhang, Jishou
    Wang, Menglong
    Ye, Jing
    Xu, Yao
    Shen, Bo
    He, Hua
    Wang, Zhen
    Ye, Di
    Zhao, Mengmeng
    Luo, Zhen
    Liu, Mingxiao
    Zhang, Pingan
    Gu, Jian
    Liu, Menglin
    Li, Dan
    Liu, Jianfang
    Wan, Jun
    HYPERTENSION, 2020, 76 (03) : 732 - 741
  • [46] Association of renin-angiotensin-aldosterone system inhibitors with mortality and testing positive of COVID-19: Meta-analysis
    Yokoyama, Yujiro
    Aikawa, Tadao
    Takagi, Hisato
    Briasoulis, Alexandros
    Kuno, Toshiki
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (04) : 2084 - 2089
  • [47] Effect of Statins and Renin-Angiotensin-Aldosterone System Inhibitors on IL-6 Levels in COVID-19 Patients
    Pereckaite, Laura
    Vaguliene, Neringa
    Vitkauskaite, Agne
    Vitkauskiene, Astra
    Urboniene, Daiva
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (21)
  • [48] Good things come in threes (and sometimes fours): Update on renin-angiotensin-aldosterone system inhibitors and COVID-19
    Quinn, Kieran L.
    Fralick, Michael
    Zipursky, Jonathan S.
    Stall, Nathan M.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2020, 192 (22) : E611 - E611
  • [49] Meta-analyses for the Effect of Renin-angiotensin-aldosterone System Inhibitors on Mortality and Testing Positive of Covid-19
    Yokoyama, Yujiro
    Takagi, Hisato
    Aikawa, Tadao
    Kuno, Toshiki
    CIRCULATION, 2020, 142
  • [50] PATIENTS' PERCEPTIONS ON THE USE OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITORS DURING THE FIRST WAVE OF THE COVID-19 PANDEMIC
    Ioannidis, Antonios
    Paraskelidou, Maria
    Pechlevanis, Apostolos
    Fragkiskou, Afroditi
    JOURNAL OF HYPERTENSION, 2021, 39 : E407 - E408
12345